← Leaderboards
Sina A Gharib
University Of Washington
$4,280,786
Attributed
$8,287,631
Total exposure
8
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,287,631 · 8
By mechanism
R01$6,100,630 · 3
R21$1,541,701 · 4
K08$645,300 · 1
Top collaborators
- Timothy Eoin West11 shared
- Narisara Chantratita5 shared
- Peter J Leary4 shared
- William A Altemeier2 shared
- Jose M. Garcia2 shared
- Anne M Manicone2 shared
Most similar at University Of Washington
Same institution · by research overlap
- Beti Thompson$30,192,370
- Katharine Anthony Bradley$17,650,205
- William A Catterall$38,660,835
- Gail Pairitz Jarvik$65,999,335
- Edwin W Rubel$15,520,530
Others in their field
Top investigators on “Mortality”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$293,517,891
- Lawrence Corey · Fred Hutchinson Cancer Center$289,968,959
- Judith S. Currier · University Of California Los Angeles$286,517,393
- James Dennis Neaton · Northwestern University$278,695,034
- Chanza Baytop · Westat, Inc.$271,217,917
- Daniel R Kuritzkes · Brigham And Women'S Hospital$261,859,249
Research focus
MortalityDiagnosisProteinsProteomicsInfectionPathway InteractionsBiologicalInhalationPlasmaMetabolomicsMultiple OmicsSamplingLeukocytesRecruitMelioidosisBacterial InfectionsSoilBurkholderia PseudomalleiIngestionPublic HealthPhenotypeClinically RelevantSepsisUniversities
Grant awards (24)
SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT)$648,806
R01 · FY2025 · CA
A plasma proteomic diagnostic for melioidosis$166,312
R21 · FY2025 · AI
A plasma proteomic diagnostic for melioidosis$44,280
R21 · FY2025 · AI
A plasma proteomic diagnostic for melioidosis$19,278
R21 · FY2025 · AI
SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT)$651,680
R01 · FY2024 · CA
Multi-omics of murine respiratory melioidosis$194,375
R21 · FY2024 · AI
A plasma metabolite diagnostic for melioidosis$179,128
R21 · FY2024 · AI
The Pulmonary Hypertension- Multi-Dimensional Omics to Characterize Right Heart Adaptation (PH-MOCHA) study$388,750
R01 · FY2023 · HL
Multi-omics of murine respiratory melioidosis$233,250
R21 · FY2023 · AI
A plasma metabolite diagnostic for melioidosis$219,765
R21 · FY2023 · AI
The Pulmonary Hypertension- Multi-Dimensional Omics to Characterize Right Heart Adaptation (PH-MOCHA) study$388,750
R01 · FY2022 · HL
Integrated Multi-omics of Melioidosis$758,287
R01 · FY2021 · AI
The Pulmonary Hypertension- Multi-Dimensional Omics to Characterize Right Heart Adaptation (PH-MOCHA) study$388,750
R01 · FY2021 · HL
Integrated Multi-omics of Melioidosis$864,642
R01 · FY2020 · AI
The Pulmonary Hypertension- Multi-Dimensional Omics to Characterize Right Heart Adaptation (PH-MOCHA) study$388,750
R01 · FY2020 · HL
Role of cannabinoid receptor 1 in lung injury and resolution$220,625
R21 · FY2020 · AI
Integrated Multi-omics of Melioidosis$871,221
R01 · FY2019 · AI
Role of cannabinoid receptor 1 in lung injury and resolution$264,688
R21 · FY2019 · AI
Integrated Multi-omics of Melioidosis$750,994
R01 · FY2018 · AI
Physiologic Genomics of Pulmonary Hypertension & RVH$129,060
K08 · FY2008 · HL · contact PI
Physiologic Genomics of Pulmonary Hypertension & RVH$129,060
K08 · FY2006 · HL · contact PI
Physiologic Genomics of Pulmonary Hypertension &RVH$129,060
K08 · FY2005 · HL
Physiologic Genomics of Pulmonary Hypertension &RVH$129,060
K08 · FY2004 · HL
Physiologic Genomics of Pulmonary Hypertension &RVH$129,060
K08 · FY2003 · HL